Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Etanercept in Psoriasis: Immunological Basis for Treatment Resistance
NCT01971346Phase 4Completed
- Sponsor
- University of Michigan
- Start
- Mar 2014
- Primary completion
- Nov 2017
- Modality
- Fc-Fusion Proteins
- Countries
- 1
01
Overview
A Phase 4 trial of etanercept in psoriasis, sponsored by University of Michigan. Started Mar 2014; status: completed.
02
Drugs
etanercept
03
Conditions
psoriasis
Beyond the preview
Go deeper on NCT01971346.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01971346.